Herpes cannot be permanently cured, but it can be effectively managed. The virus hides inside nerve cells in a dormant state that current medications can’t reach. What you can do is shorten outbreaks, reduce their frequency, and in many cases go long stretches without symptoms at all. The difference between unmanaged herpes and well-managed herpes is significant, both in how you feel and how likely you are to transmit it.
Why Herpes Can’t Be Fully Eliminated
After an initial infection at the mouth or genitals, the herpes simplex virus travels along nerve fibers into clusters of nerve cells called sensory ganglia near the spine. Once there, the virus essentially goes to sleep. It shuts down most of its gene activity and sits inside the neuron without producing new copies of itself. Your immune system can’t detect it in this state, and antiviral medications only work against actively replicating virus.
Periodically, something triggers the virus to wake up. When it reactivates, it travels back down the nerve to the skin surface, where it can cause a new outbreak or shed invisibly without any symptoms. This cycle of dormancy and reactivation is why herpes is a lifelong infection, but it’s also why treatment focuses on two practical goals: healing active outbreaks faster and preventing future ones.
What Triggers an Outbreak
Reactivation happens when something disrupts the immune surveillance keeping the virus dormant. The most well-documented triggers include psychological stress, UV light exposure, physical exhaustion, fever, hormonal changes, and illness. These aren’t vague associations. Stress raises corticosteroid levels, which suppress the immune signaling that keeps the virus in check. UV radiation, particularly UV-B, directly suppresses the skin’s ability to present herpes antigens to immune cells and activates a viral promoter that kickstarts replication.
Knowing your personal triggers gives you some control. If sun exposure is a pattern for you, consistent use of SPF lip balm or sunscreen on affected areas can make a real difference. If outbreaks correlate with periods of high stress or poor sleep, those are signals worth paying attention to. Some people notice outbreaks after dental work, during menstruation, or when they’re fighting off a cold. Tracking what precedes your outbreaks helps you anticipate and sometimes prevent them.
Antiviral Medications for Outbreaks
Three prescription antivirals form the backbone of herpes treatment: acyclovir, valacyclovir, and famciclovir. All three work by blocking the virus from copying its DNA during active replication. They don’t kill the virus, but they stop it from multiplying, which lets your immune system clear the outbreak faster.
For a first outbreak, treatment typically lasts 7 to 10 days and can be extended if sores haven’t fully healed. First episodes tend to be the most severe, with more widespread sores and sometimes flu-like symptoms, so the longer course matters.
Recurrent outbreaks are shorter and milder. Episodic treatment, meaning you take medication at the first sign of an outbreak, can last as little as 1 to 5 days depending on the specific medication and dose. The key is starting early. If you can begin taking your antiviral during the tingling or itching stage before sores appear, you can sometimes prevent the outbreak from fully developing. Many people keep a prescription on hand for exactly this reason.
Suppressive Therapy for Frequent Outbreaks
If you’re getting outbreaks regularly, daily antiviral therapy can dramatically reduce how often they happen. Suppressive therapy means taking a low dose every day, not just during outbreaks. For many people, this means going from several outbreaks a year to one or none.
Beyond reducing your own symptoms, daily suppressive therapy cuts the risk of transmitting herpes to a partner. A landmark study found that daily valacyclovir reduced transmission to an uninfected partner by 48%, dropping the rate from 3.6% to 1.9% over eight months. Combined with condom use, the risk drops further. This is often a major motivator for people who choose suppressive therapy, especially in relationships where one partner doesn’t carry the virus.
Suppressive therapy is generally well tolerated for long-term use. Some people stay on it for years, while others use it for a period and then switch to episodic treatment as their outbreaks naturally become less frequent over time, which they often do.
How Long Outbreaks Take to Heal
A first genital herpes outbreak typically takes two to three weeks to heal completely without treatment. With antivirals started promptly, that window tightens to roughly 7 to 10 days. Recurrent outbreaks are naturally shorter, often resolving in about a week without treatment and faster with episodic antivirals.
During healing, sores progress through predictable stages: tingling or itching, then blisters, then open ulcers, then crusting and scabbing, and finally new skin. Keeping the area clean and dry helps. Avoid touching sores and wash your hands if you do, since the virus can be transferred to other body sites. Loose, breathable clothing reduces irritation for genital outbreaks. Over-the-counter pain relief can help with discomfort during the blister and ulcer stages.
L-Lysine and Other Non-Prescription Approaches
L-lysine is the most studied supplement for herpes prevention. It works by competing with arginine, an amino acid the virus needs to replicate. The evidence is mixed but leans positive at higher doses. Supplementation below 1 gram per day appears ineffective, while doses above 1 gram daily have shown meaningful reductions in outbreak frequency across multiple trials. One study found a 40% reduction in recurrences over three months at 1 gram per day. Another found that 62.5% of people in the lysine group had decreased recurrences compared to 14.2% on placebo.
The practical takeaway: if you want to try lysine, aim for at least 1 gram daily, and reducing high-arginine foods (like nuts, chocolate, and seeds) may improve results. Doses above 3 grams per day appear to improve how people experience outbreaks subjectively. However, people with cardiovascular disease, gallstones, or asthma should be cautious with lysine supplementation due to theoretical risks.
Other non-prescription strategies have less robust evidence. Some people report benefits from topical honey, zinc, or lemon balm applied to sores, but the clinical data behind these is thin compared to antivirals. They’re unlikely to cause harm if you want to try them alongside standard treatment, but they shouldn’t replace antiviral medication for active outbreaks.
Getting an Accurate Diagnosis
If you haven’t been formally diagnosed, the type of test matters. Swab tests taken directly from an active sore are the most reliable for confirming herpes and identifying whether it’s HSV-1 or HSV-2. Blood tests measure antibodies and can detect past infection even without symptoms, but their accuracy varies. For HSV-2, modern blood tests perform well, with sensitivity around 95 to 98% and specificity above 94%. HSV-1 blood testing is less reliable, with sensitivity ranging from about 80 to 92% depending on the test platform.
Knowing your type matters for practical reasons. HSV-2 genital infections tend to recur more frequently than genital HSV-1, which often causes fewer and milder recurrences over time. This distinction affects decisions about suppressive therapy and what to expect long-term.
Reducing Transmission to Partners
Herpes spreads through direct skin-to-skin contact, and it can transmit even when no sores are visible. This invisible shedding is actually responsible for a large share of new infections. Three strategies reduce transmission risk substantially when combined: daily suppressive antiviral therapy, consistent condom use, and avoiding sexual contact during active outbreaks or prodromal symptoms like tingling or itching.
No single method eliminates risk entirely, but layering them together brings the probability of transmission quite low. Having an honest conversation with partners, while difficult, is also practically important because it allows both people to make informed choices about risk reduction.
What the Treatment Pipeline Looks Like
A new class of antiviral called a helicase-primase inhibitor, pritelivir, works through a completely different mechanism than current medications and has shown promising results. In clinical trials, it reduced viral shedding and lesions more effectively than valacyclovir in people with genital HSV-2. It’s currently being studied for people whose herpes is resistant to standard antivirals, where it healed lesions in 93% of participants compared to 57% on the alternative treatment, with far fewer side effects.
On the vaccine front, Moderna has been testing an mRNA-based therapeutic vaccine (mRNA-1608) for people who already have HSV-2, with Phase 1/2 trials completed in early 2025. A therapeutic vaccine wouldn’t prevent infection but could train the immune system to suppress reactivation more effectively, potentially reducing outbreaks and shedding without daily medication. Neither pritelivir nor the vaccine is available yet, but they represent the most concrete progress toward better herpes treatment in decades.